Vasculogenic mimicry has no prognostic significance in pT3 and pT4 cutaneous melanoma

Daniela Massi1, Alessandro Franchi, Milena Paglierani

  • 1Department of Human Pathology and Oncology, University of Florence, Florence, Italy.

Human Pathology
|April 30, 2004
PubMed

Insights

Vasculogenic mimicry, characterized by tumor cell-lined channels, does not appear to predict outcomes in thick cutaneous melanoma. This study found no significant prognostic role for these patterns in advanced skin cancer.

Area of Science:

  • Oncology
  • Dermatology
  • Cancer Biology

Background:

  • Vasculogenic mimicry (VM) involves tumor cells forming PAS-positive channels, mimicking microvasculature.
  • Previous research linked VM to poor prognosis in uveal melanoma.

Purpose of the Study:

  • To investigate the prognostic significance of VM in pT3 and pT4 cutaneous melanoma.
  • To determine if VM patterns correlate with clinical outcomes in advanced skin cancer.

Main Methods:

  • Tumor sections from 15 pT3/pT4 cutaneous melanoma patients with 10-year progression-free survival and 30 matched controls were analyzed.
  • Periodic acid-Schiff (PAS) staining identified VM patterns.
  • Immunohistochemistry for CD31, CD105, and laminin assessed blood vessel architecture.
  • Statistical analysis (Pearson chi², Mann-Whitney U) compared VM distribution and clinicopathological variables.

Main Results:

  • PAS-positive patterns (linear sheets, arcs, loops, networks) were observed, distinct from endothelial blood vessels.
  • No significant difference in VM pattern distribution was found between progression-free patients and those who progressed.
  • A parallel VM pattern correlated with increased tumor thickness but inversely with vessel area.

Conclusions:

  • The study found a mismatch between VM and tumor angiogenesis in thick cutaneous melanoma.
  • Vasculogenic mimicry does not appear to have a prognostic role in pT3 and pT4 cutaneous melanoma.
  • Further research is needed to clarify the role of VM in different cancer types.